Pulmonary Fibrosis News Columnist and Forum Moderator Charlene Marshall reads an article on the effectiveness of AP01 (inhaled pirfenidone) following an Australian study on IPF patients.

Both the safety profile and side effects are promising, along with the hope from the pharmaceutical company that more of the drug will get into the lungs via an aerosol consumption method.

Are you interested in learning more about Pulmonary Fibrosis? If so, please visit: https://pulmonaryfibrosisnews.com

Podden och tillhörande omslagsbild på den här sidan tillhör Pulmonary Fibrosis News. Innehållet i podden är skapat av Pulmonary Fibrosis News och inte av, eller tillsammans med, Poddtoppen.